Difference between revisions of "Brenner tumour"

From Libre Pathology
Jump to navigation Jump to search
(split out)
(tweak some more)
Line 1: Line 1:
The '''Brenner tumour''' is an [[ovarian tumour]] in the epithelial group of ovarian tumours.
The '''Brenner tumour''', abbreviated '''BT''', is an [[ovarian tumour]] in the epithelial group of ovarian tumours.


==General==
==General==
*Fits into the ''transistional cell tumours'' category - in the surface epithelial group of ovarian tumours.
*Considered to be rare.<ref>{{Cite journal  | last1 = Bilici | first1 = A. | last2 = Inanc | first2 = M. | last3 = Ulas | first3 = A. | last4 = Akman | first4 = T. | last5 = Seker | first5 = M. | last6 = Babacan | first6 = NA. | last7 = Inal | first7 = A. | last8 = Bal | first8 = O. | last9 = Koral | first9 = L. | title = Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology. | journal = Asian Pac J Cancer Prev | volume = 14 | issue = 11 | pages = 6493-9 | month =  | year = 2013 | doi =  | PMID = 24377556 }}</ref>
*Traditionally, BT has been grouped within the ''transistional cell tumours'' category in the surface epithelial group of ovarian tumours.
**Recently, [[transistional cell carcinoma of the ovary]] has been related to [[serous carcinoma]]; TCC of the ovary is probably distinct from the malignant Brenner tumour.<ref>{{Cite journal  | last1 = Ali | first1 = RH. | last2 = Seidman | first2 = JD. | last3 = Luk | first3 = M. | last4 = Kalloger | first4 = S. | last5 = Gilks | first5 = CB. | title = Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor. | journal = Int J Gynecol Pathol | volume = 31 | issue = 6 | pages = 499-506 | month = Nov | year = 2012 | doi = 10.1097/PGP.0b013e31824d7445 | PMID = 23018212 }}</ref>


===Epidemiology===
===Epidemiology===
Line 42: Line 44:
Image:Brenner tumour intermed mag.jpg | BT - intermed. mag. (WC)
Image:Brenner tumour intermed mag.jpg | BT - intermed. mag. (WC)
</gallery>
</gallery>
==IHC==
Features:<ref>{{Cite journal  | last1 = Kuhn | first1 = E. | last2 = Ayhan | first2 = A. | last3 = Shih | first3 = IeM. | last4 = Seidman | first4 = JD. | last5 = Kurman | first5 = RJ. | title = Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. | journal = Eur J Cancer | volume = 49 | issue = 18 | pages = 3839-49 | month = Dec | year = 2013 | doi = 10.1016/j.ejca.2013.08.011 | PMID = 24012099 }}</ref>
*AR +ve.
*Calretinin -ve.
**Surrounding stroma +ve.


==See also==
==See also==

Revision as of 09:22, 14 February 2014

The Brenner tumour, abbreviated BT, is an ovarian tumour in the epithelial group of ovarian tumours.

General

  • Considered to be rare.[1]
  • Traditionally, BT has been grouped within the transistional cell tumours category in the surface epithelial group of ovarian tumours.

Epidemiology

  • Mostly benign clinical course.
  • Thought to arise from Walthard cell rest.
  • Frequently an incidental finding, i.e. oophorectomy was done for another reason.
  • May be malignant.

Gross

Features:[3]

  • Classically solid, well-circumscribed, light yellow.
  • May be cystic.

Note:

  • Borderline tumours classically solid and cystic with papillary projections into the cystic component.[3]

Microscopic

Features:

  • Nests of transitional epithelium with cells that have:[4]
    • A "coffee bean nucleus".
      • Elliptical shape (nucleus).
      • Nuclear grooves.[5]
      • Distinct nucleoli.
    • Moderate-to-abundant gray/pale cytoplasm.
  • Dense fibrous stroma around nests.

Notes:

DDx:

Images

IHC

Features:[6]

  • AR +ve.
  • Calretinin -ve.
    • Surrounding stroma +ve.

See also

References

  1. Bilici, A.; Inanc, M.; Ulas, A.; Akman, T.; Seker, M.; Babacan, NA.; Inal, A.; Bal, O. et al. (2013). "Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.". Asian Pac J Cancer Prev 14 (11): 6493-9. PMID 24377556.
  2. Ali, RH.; Seidman, JD.; Luk, M.; Kalloger, S.; Gilks, CB. (Nov 2012). "Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.". Int J Gynecol Pathol 31 (6): 499-506. doi:10.1097/PGP.0b013e31824d7445. PMID 23018212.
  3. 3.0 3.1 Borah, T.; Mahanta, RK.; Bora, BD.; Saikia, S. (Jan 2011). "Brenner tumor of ovary: An incidental finding.". J Midlife Health 2 (1): 40-1. doi:10.4103/0976-7800.83273. PMC 3156501. PMID 21897739. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156501/.
  4. Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 1098. ISBN 0-7216-0187-1.
  5. URL: http://www.pathologyoutlines.com/ovarytumor.html#brennergen. Accessed on: 8 February 2011.
  6. Kuhn, E.; Ayhan, A.; Shih, IeM.; Seidman, JD.; Kurman, RJ. (Dec 2013). "Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.". Eur J Cancer 49 (18): 3839-49. doi:10.1016/j.ejca.2013.08.011. PMID 24012099.